Skip to content
POM-VPS Prescription Required

Embotape Oral Paste 40% w/w

Active ingredient: Pyrantel Embonate

Form

Paste

Species

Horses

Manufacturer

Bimeda Animal Health Limited

VMD MA No.

50146/4014

What it's used for

Pyrantel embonate is a broad spectrum anthelmintic. Pyrantel embonate is indicated for use in the horse for the control and treatment of adult infections o...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Pyrantel Embonate

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Embotape Oral Paste 40% w/w — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Pyrantel embonate is a broad spectrum anthelmintic. Pyrantel
embonate is indicated for use in the horse for the control and
treatment of adult infections of large and small strongyles,
Pinworms, Roundworms, Tapeworms.
Pyrantel embonate has a broad spectrum of activity, including
activity against:
Large strongyles:
Small strongyles: spp. (Cyathostomes),
Triodontophorus spp.
Pinworms
Large roundworms:
Tape worms:

Revised: July 2025
AN: 01009/2025
Control and treatment of Strongyles, Oxyuris and Parascaris
Embotape should be used at a dose rate of 19 mg pyrantel
embonate per kg bodyweight.
The prescribed amount of Embotape is deposited on the tongue of
the animal and the animal allowed to swallow. The complete
content of one syringe contains 11.4g pyrantel embonate (6
graduated doses of 1.9g) in 28.5g paste and is sufficient for the
treatment of 600kg bodyweight. Each graduation of the syringe is
sufficient for the treatment of 100kg body-weight.

Revised: July 2025
AN: 01009/2025
Control and treatment of Anoplocephala (Tapeworm)
Embotape should be used at a dose rate of 38mg pyrantel
embonate per kg bodyweight (i.e. twice the dose used for
stronglyes).
To ensure administration of a correct dose, body weight should be
determined as accurately as possible; accuracy of the dosing
device should be checked.
Inappropriate use of anthelmintics may increase resistance
selection pressure and lead to reduced efficacy. The decision to
use the product should be based on professional advice and take
into account current best practice recommendations for parasite
control.
Not for use in foals less than 4 weeks of age.
Contraindicated in known sensitivity to pyrantel and in severely
debilitated animals.
Pyrantel embonate is safe for horses and ponies of all ages,
including sucklings, pregnant mares and studs. Impaction of the
small intestine may occur in foals, infected with high numbers of
Parascaris equorum. Symptoms (colic) may be seen as soon as
30 minutes after treatment
Care should be taken to avoid the following practices because they
increase the risk of development of resistence and could ultimately
result in ineffective therapy:

same class, over an extended period of time.

weight, misadministeration of the product, or lack of
calibration of the dosing device(if any).
Suspected clinical cases of resistence to anthelmintics should be
further investigated using appropriate tests (e.g. Faecal Egg Count
Reduction Test). Where the results of the test(s) strongly suggest
resistance to a particular anthelmintic, an anthelmintic belonging to
another pharmacological class and having a different mode of
action should be used.
Resistance to pyrantel has been reported in cyathostomes in
horses (also widespread in the USA and Canada). Therefore the
use of this product should be based on local (regional, farm)
epidemiological information about susceptibility of nematodes and
recommendations on how to limit further selection for resistence to
anthelmintics.

Special precautions for use in animals
The same syringe should only be used to dose two animals if they
are both healthy and are either running together, or are on the
same premises and in direct contact with each other.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Direct contact with the skin should be avoided.
Wash hands and any other parts of the body which comes into
contact with the product after use.

Revised: July 2025
AN: 01009/2025
Avoid handling the product if you know you are hypersensitive to
pyrantel.
of Interactions
Combined administration of pyrantel and levamisole or piperazine
is not recommended.
Do not store above 25°C.
Protect from direct sunlight.
Not to be used in horses and ponies intended for human
consumption.
Treated horses may never be slaughtered for human consumption.
The horse must have been declared as not intended for human
consumption under national horse passport legislation.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.